MannKind (MNKD) Competitor Comparison
We are evaluating the key criteria listed to compare MannKind (MNKD) against its competitors in the Biotechnology industry.
Market Capitalization
127 / 368Gross Profits
68 / 278Total Revenue
65 / 300EBITDA
35 / 337Free Cashflow
205 / 352Quick Ratio
299 / 357Earnings per Share
42 / 359Dividend yield
0 / 6Total Cash
184 / 358Performance 3 years
62 / 368Performance 5 years
18 / 368Performance 10 years
189 / 368Linearity 3 years
130 / 368Linearity 5 years
364 / 368Linearity 10 years
268 / 368Total Rank
333 / 368Dividend Rank
196 / 368Valuation Rank
278 / 368Piotroski Rank
295 / 368Muliplier Rank
149 / 368Valuation Rank - MNKD ranking 278 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.